Chief Quality Officer

Corporate Quality Operations
Business Area: Quality
Contract Type: Permanent
Parma, Dublin or locations in IT
Based in Parma, Italy, Chiesi is an international research-focused pharmaceutical and healthcare group with over 85 years’ experience, operating in 30 countries with more than 6,000 employees (Chiesi Group). To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, the Group researches, develops and markets innovative drugs in its main therapeutic areas: We are proud to be the largest global pharmaceutical group to be awarded B Corp Certification , a recognition of high social and environmental standards . Our people make a critical difference to our success, which is why it is vital that we attract and retain the right talent who will continue to enrich our culture by living and breathing our values and behaviors.
In fact, we are a global family made up of different cultures, different genders, generations, ethnicities, abilities, sexual identities and many other enriching diversities.
Chiesi Global Manufacturing Division
Chiesi Group has three production plants:
Parma (Italy), the strategic hub for the production and distribution of our products, serving as an international supply center with exports to over 80 countries. Here, solid medicines such as tablets and dry powders for inhalers, solutions and suspensions for inhalations and sterile suspension vials for endotracheal administration are produced.
In 2024, a new Biotech Centre of Excellence has launched in Parma. Blois-La Chaussée Saint Victor plant (France), a center of excellence specializing in the production of Dry Powder Inhalers and Metered Dose Inhalers (MDIs). The site manages direct distribution to customers in the French market and exports to other markets, effectively meeting both local and international needs.
Santana de Parnaiba (Brazil), specialized in the production of pressurized solutions and suspensions for inhalation therapy (pMDIs). Additionally, it has an area dedicated to nasal sprays for the European market. Santana produces pressurised solutions and suspensions for inhalation therapy (MDI).
In 2025, a new investment in Nerviano (Italy) has been announced with the construction of a new facility which will be primarily dedicated to manufacturing carbon minimal inhalers (reinforcing the company’s commitment to both patients’ health and sustainable healthcare solutions), dry powder inhalers and sterile biological products.
The Global Quality Process Head is a strategic leader responsible for designing, implementing, and maintaining a harmonized, compliant, and efficient Quality Management System (QMS) across all global pharmaceutical operations. This role ensures alignment with regulatory requirements, supports product lifecycle management and drives a culture of continuous improvement and quality excellence.
Develop and lead the global QMS strategy, ensuring alignment with business goals and regulatory expectations.
Establish governance frameworks for quality systems oversight
Ensure QMS compliance with global regulatory standards
CAPA, Change Control, Deviations, Document Management & Training
Drive harmonization and simplification of quality processes across sites and functions.
Support the implementation and optimization of electronic QMS platforms (e.g., Lead global training needs for the global quality organisation
Lead and develop a global team of quality systems professionals
Collaborate cross functionally with stakeholders reg affairs, IT, operations, engineering
Lead collaboration forums for QMS quality systems across the network globally with the local quality system process owners to drive best practices and continuous improvements
Bachelor’s degree in Pharmacy, Life Sciences, Engineering, or related field (Master’s or PhD preferred).
Minimum 15 years of experience in pharmaceutical quality systems, with at least 5 years in a global leadership role.
Proven experience in leading QMS transformations and digital implementations.
Experience with regulatory inspections (FDA, EMA, PMDA, etc.).
Expertise in clinical & commercial GMP/GDP quality systems.
Hybrid – Parma, Dublin or other strategic locations in Europe
In Chiesi we firmly believe that our people are our most valuable asset , that is why we invest in continuous training, learning and development. Therefore, we strive to continuously promote and satisfy development needs, paying particular attention to the quality of our working environment and to collective well-being.
That is why we offer flexible working approach, remote working, support in the relocation process, tax assistance service for foreign colleagues and many other people-care services.
#